Manuel Pereira Barbosa

Manuel Pereira Barbosa

Auto-generated profile, based on publicly available information

Manuel Pereira Barbosa

Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisboa, Portugal

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
JCJoana Caiado
Joana Caiado
LVLennart Venemalm
Lennart Venemalm
MPMaria Conceição Pereira-Santos
Maria Conceição Pereira-Santos
LCLuis Costa
Luis Costa
MBManuel Pereira Barbosa
Manuel Pereira Barbosa
MCMariana Castells
Mariana Castells

3 August 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RBRita R. Barbosa
Rita R. Barbosa
SSSara P. Silva
Sara P. Silva
SSSusana L. Silva
Susana L. Silva
AMAlcinda Campos Melo
Alcinda Campos Melo
EPElisa Pedro
Elisa Pedro
ASAna E Sousa
Ana E Sousa
IL-17 is a pro-inflammatory cytokine implicated in autoimmune and inflammatory conditions. The development/survival of IL-17-producing CD4 T cells (Th17) share critical cues with B-cell differentiation and the circulating follicular T helper subset was recently shown to be enriched in Th17 cells able to help B-cell differentiation. We investigated a putative link between Th17-cell homeostasis and B cells by studying the Th17-cell compartment in primary B-cell immunodeficiencies. Common Variable Immunodeficiency Disorders (CVID), defined by defects in B-cell differentiation into plasma and memory B cells, are frequently associated with autoimmune and inflammatory manifestations but we found no relationship between these and Th17-cell frequency. In fact, CVID patients showed a decrease in Th17-cell frequency in parallel with the expansion of activated non-differentiated B cells (CD21lowCD38low). Moreover, Congenital Agammaglobulinemia patients, lacking B cells due to impaired early B-cell development, had a severe reduction of circulating Th17 cells. Finally, we found a direct correlation in healthy individuals between circulating Th17-cell frequency and both switched-memory B cells and serum BAFF levels, a crucial cytokine for B-cell survival. Overall, our data support a relationship between Th17-cell homeostasis and B-cell maturation, with implications for the understanding of the pathogenesis of inflammatory/autoimmune diseases and the physiology of B-cell depleting therapies.

21 May 2012 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
RBR. R. Barbosa
R. R. Barbosa
SSS. P. Silva
S. P. Silva
SSS. L. Silva
S. L. Silva
RTR. Tendeiro
R. Tendeiro
AMA. C. Melo
A. C. Melo
ASAna E Sousa
Ana E Sousa
Common variable immunodeficiency disorders (CVID), the most frequent cause of symptomatic primary immunodeficiency, are defined by impaired antibody production. Notwithstanding, T cell activation and granulomatous manifestations represent the main causes of CVID morbidity even in patients receiving immunoglobulin (Ig) G replacement therapy. Additionally, gut pathology is a frequent feature of CVID. In this study, we investigated monocyte imbalances and their possible relationship with increased microbial translocation in CVID patients. Monocyte subsets were defined according to CD14 and CD16 expression levels and evaluated in terms of human leucocyte antigen D‐related (HLA‐DR), CD86 and programmed death‐1 molecule ligand 1 (PD‐L1) expression by flow cytometry, in parallel with the quantification of plasma lipopolysaccharide (LPS) and serum levels of soluble CD14 (sCD14), LPS‐binding protein (LBP) and anti‐LPS antibodies. CVID patients (n = 31) featured significantly increased levels of serum sCD14 and an expansion of CD14brightCD16+ monocytes in direct correlation with T cell and B cell activation, the latter illustrated by the frequency of the CD21lowCD38low subset. Such alterations were not observed in patients lacking B cells due to congenital agammaglobulinaemia (n = 4). Moreover, we found no significant increase in circulating LPS or LBP levels in CVID patients, together with a relative preservation of serum anti‐LPS antibodies, in agreement with their presence in commercial IgG preparations. In conclusion, CVID was associated with monocyte imbalances that correlated directly with T cell activation markers and with B cell imbalances, without an association with plasma LPS levels. The heightened monocyte activated state observed in CVID may represent an important target for complementary therapeutic strategies.

7 December 2007 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
MPM. C. Pereira‐Santos
M. C. Pereira‐Santos
ABA. P. Baptista
A. P. Baptista
AMA. Melo
A. Melo
RAR. R. Alves
R. R. Alves
Rui SoaresRui Soares
Rui Soares
ASAna E Sousa
Ana E Sousa

1 January 1997 in Allergy
Verified
Journal Article
Closed access
PDF file
MFManuel Ferreira
Manuel Ferreira
MCM. H. Clode
M. H. Clode
MPM. A. Pereira‐Barbosa
M. A. Pereira‐Barbosa
APA. G. Palma‐Carlos
A. G. Palma‐Carlos

26 November 2008 in International Archives of Allergy and Immunology
Verified
Journal Article
Closed access
RARodrigo Rodrigues Alves
Rodrigo Rodrigues Alves
ALAnabela Lopez
Anabela Lopez
MPMaria Conceição Pereira-Santos
Maria Conceição Pereira-Santos
SLSusana Lopes-Silva
Susana Lopes-Silva
ASAmélia Spínola-Santos
Amélia Spínola-Santos
MPManuel Pereira-Barbosa
Manuel Pereira-Barbosa
Background: Peach is a common food allergen source throughout Europe. The aim of this study was to characterize peach allergy in a Portuguese patient population. Methods: Thirty peach-allergic patients confirmed by double-blind placebo-controlled food challenges and 29 controls were included. All subjects completed a standardized questionnaire regarding symptoms and epidemiologic characteristics, skin prick tests with inhalant allergens and foods as well as specific IgE antibodies to peach, recombinant peach allergens rPru p 1, rPru p 3, rPru p 4 and cross-reactive carbohydrate determinants. Results: Thirty-seven percent of patients reported only oral allergy syndrome, while 37% reported generalized urticaria and/or angioedema, 17% localized contact urticaria and 10% anaphylaxis with peach. Sensitization to other Rosaceae fruits and tree nuts was present in 90 and 77% of the patients, respectively. Respiratory allergy history was associated with less severe symptoms (oral allergy syndrome or contact urticaria; p < 0.01) and positive skin prick test to peach peel or plum with more severe symptoms (urticaria and/or angioedema or anaphylaxis; p < 0.05). Ninety-seven percent were sensitized to Pru p 3, 13% to Pru p 4, 3% to Pru p 1 and 10% to cross-reactive carbohydrate determinants. Pru p 3 specific IgE was associated with Artemisia vulgaris sensitization and tree nut allergy (p < 0.05) but not with clinical severity. Conclusions: Half the patients reported systemic reactions to peach. Peach allergy appeared predominantly mediated by Pru p 3 but some patients were sensitized to Pru p 4. Applying a 0.10 kUA/l cutoff level, the diagnostic value of combining the 3 recombinant allergens was noteworthy, with 100% sensitivity and 90% specificity.